Subcutaneous Extended-Release Buprenorphine Use in Pregnancy
المؤلفون المشاركون
Towers, Craig V.
Deisher, Heather
المصدر
Case Reports in Obstetrics and Gynecology
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-3، 3ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-07-17
دولة النشر
مصر
عدد الصفحات
3
التخصصات الرئيسية
الملخص EN
Background.
Opioid use disorder (OUD) in pregnancy is managed by medication-assisted treatment.
Sublingual buprenorphine is one option, but subcutaneous extended-release buprenorphine (Sublocade®) is an alternate form administered in monthly injections.
Through an extensive literature search, we did not find any prior publication on the use of Sublocade in pregnancy.
Case.
Two patients with OUD switched from sublingual buprenorphine to Sublocade.
One patient received a total of eight injections and then discovered she was pregnant.
Based on ultrasound dating, the last 5 administrations occurred during her pregnancy.
The second patient received 6 injections with the last occurring at the time of her last menstrual period.
Both declined further injections, as well as oral buprenorphine.
Serial urine drug screens remained positive for buprenorphine through delivery in both cases.
Neither the mothers nor the neonates experienced withdrawal symptoms or adverse outcomes.
No birth anomalies were found.
Discussion.
Though further research is needed regarding the use of Sublocade in pregnancy, it is likely that other pregnancies will occur during this treatment modality.
If this long-acting form of buprenorphine medication is found to be safe, it might play a role in managing some pregnant patients with OUD.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Towers, Craig V.& Deisher, Heather. 2020. Subcutaneous Extended-Release Buprenorphine Use in Pregnancy. Case Reports in Obstetrics and Gynecology،Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1149090
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Towers, Craig V.& Deisher, Heather. Subcutaneous Extended-Release Buprenorphine Use in Pregnancy. Case Reports in Obstetrics and Gynecology No. 2020 (2020), pp.1-3.
https://search.emarefa.net/detail/BIM-1149090
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Towers, Craig V.& Deisher, Heather. Subcutaneous Extended-Release Buprenorphine Use in Pregnancy. Case Reports in Obstetrics and Gynecology. 2020. Vol. 2020, no. 2020, pp.1-3.
https://search.emarefa.net/detail/BIM-1149090
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1149090
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر